Due to the negative correlation between CRIP1 expression and survival time in gastric cancer patients, FBXO5 may exhibit a potential protective role in the prognosis of gastric cancer through inhibiting the identified function of CRIP1 in this report. This evidence concerns the gene CRIP1 and gastric cancer.